Plain-English translation of NCT06073431 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is trying to understand cancer cachexia—a condition where patients with advanced cancer lose weight and muscle mass even when eating well. Researchers want to identify different types of this condition by tracking physical activity, fitness, body composition, and blood tests over time in patients with advanced lung, pancreatic, or colorectal cancer. By studying these patterns, they hope to better predict which patients are at highest risk and eventually develop better treatments.
Cancer-related weight loss and muscle loss significantly affect how well patients tolerate treatment and their overall survival, but doctors don't yet fully understand why some patients experience it differently than others. This study exists to uncover the different underlying causes so that future treatments can be personalized.
You likely qualify if…
You likely don't qualify if…
You would visit the study site at baseline and again at 3 months, completing a 30-minute survey about your symptoms and a 30-minute physical fitness test. You'll wear a small activity monitor for 7 days at each visit to track your daily movement and sleep. The study team will collect a blood sample and review your existing tumor tissue, and they'll track your standard cancer imaging scans and medical records for up to 1 year. Overall, this is an observational study—researchers are watching and recording changes rather than testing a new medication.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States